GYRE Therapeutics COO Ye Weiguo Executes Stock Transactions Amid Corporate Expansion
GYRE THERAPEUTICS, INC. (NASDAQ:GYRE) Chief Operating Officer Ye Weiguo executed a series of stock transactions on June 11, 2026, selling 2,800 shares for $17,276 after exercising fully vested options. The disclosure follows significant corporate developments, including the acceptance of a New Drug Application for F351 by China's National Medical P…